News Industry News FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor July 11, 2016
News Industry News Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease March 01, 2016
News Industry News Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease October 12, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015